Skip to main content

Table 2 EDSS scores in each month during the study period

From: The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

EDSS scores Groups Mean Standard deviation Minimum Maximum F Sig
Month 1 Study 5.45 0.15 5 5.5 14.46 0.00
Control 4.52 1.09 3 6
Month 2 Study 5.45 0.15 5 5.5 14.46 0.00
Control 4.52 1.09 3 6
Month 3 Study 5.45 0.39 5.4 6 11.93 0.00
Control 4.55 1.12 3 6.5
Month 4 Study 5.25 0.55 4 6 5.38 0.03
Control 4.63 1.10 3 6.5
Month 5 Study 5.10 0.68 4 6 0.99 0.33
Control 4.83 1.06 3 6.5
Month 6 Study 4.95 0.74 3 6 0.13 0.72
Control 4.85 1.08 3 6.5
Month 7 Study 4.85 0.75 3 5.5 1.00 0.96
Control 4.87 1.15 3 7
Month 8 Study 4.63 0.94 3 6 1.30 0.26
Control 4.97 1.10 3 7
Month 9 Study 455 0.93 3 6 3.74 0.06
Control 5.13 1.11 3.5 7
Month 10 Study 4.33 1.12 2.5 6 6.35 0.02
Control 5.15 1.15 3 7
Month 11 Study 4.13 1.35 2 6 7.63 0.01
Control 5.12 1.17 3 7
Month 12 Study 3.98 1.37 2 6 9.54 0.00
Control 5.10 1.18 3 7